Researchers found three distinct patterns of CTE brain changes, and one pattern with heavy cortex damage was linked to worse daily functioning.
CTE, a brain disease tied to repeated head hits, does not look the same in every person; the study found three main patterns of brain changes. Subtype 1 had lots of abnormal tau protein build-up in the brain cortex (the brain's outer layer) and this pattern progressed quickly, like paint spreading over a large wall. Subtype 2 showed less cortex involvement but more damage in the hippocampus (a deep brain area important for memory), like a focused stain in one room rather than all over the house. Subtype 3 was seen mostly in older people and came with other brain problems such as Alzheimer-type changes, so the damage mixed together like several colors blending. Only people with Subtype 1 patterns showed a clear link between the amount of abnormal tau and worse daily functioning, meaning more cortical damage matched more trouble with everyday tasks.
People with MS and their caregivers should care because similar problems—like memory loss, thinking changes, or trouble with daily tasks—can also happen in MS, and this study shows brain disease can look different person to person. Knowing there are different CTE patterns is like knowing that not all fevers come from the same bug; treatment and support need to fit the pattern. Caregivers can use this idea to push for more tailored assessments if someone with a history of head hits shows changes, instead of assuming one single cause. Doctors and therapists might use this information to check different parts of the brain or try different support plans, for example focusing more on memory help if the hippocampus is involved. Overall, it highlights that personalized testing and care plans are important—what helps one person may not help another.
The study looked at brain tissue after death, so the patterns were found by examining brains directly and cannot yet be seen inside living people with current tests. The sample mostly came from people with a history of repeated head hits in sports, so the results might not apply the same way to everyone. Also, while one pattern linked to worse daily function, this is not proof that the pattern causes the problems—other mixed brain issues could play a role.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/31/2026
Researchers found consistent gut bacteria differences in MS tied to disease type, treatment response
Read More9/1/2026
A small study found Ma/Ma2 antibodies can cause nerve-only symptoms often linked to cancer; testing
Read More7/1/2026
Study shows aerobic exercise alters brain circuits linked to automatic body control and fatigue in M
Read More7/1/2026
A simple eye scan and a blood test for sGFAP together help identify people with MS at higher risk of
Read More7/1/2026
MRI shows the choroid plexus is larger early in MS and links to inflammation and certain genes, sugg
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Acta neuropathologica often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.